E-cigarette Notification Scheme Lead
(MHRA) The Medicines and Healthcare Products Regulatory Agency
Beryl Keeley has a background in biochemistry and has worked in various areas in Government and previously in the pharmaceutical industry. Currently Beryl is Advertising Standards Unit Manager within the Vigilance and Risk Management of Medicines Division of the Medicines and Healthcare products Regulatory Agency. The Unit has responsibility for the regulation of medicines advertising in the UK. In this capacity Beryl has worked extensively to promote high standards in all medicines, and recently has been working with industry on the first product that fulfils the official definition of an e-cigarette to go through medicines licensing procedures and receive a marketing authorisation.
Beryl and the MHRA team are responsible for implementing the e-cigarette notification scheme and new regulatory framework under Article 20 of the Tobacco Products Directive. She brings experience in public perception and industry engagement around Nicotine Replacement Therapy and other medicines to the new functionality of MHRA in regulating e-cigarettes and consumer products. Understanding the clear and important differences between licensed NRT and the consumer products that make up the vast majority of the vaping industry serves an important purpose in Government plans for implementation and the introduction of a separate regulatory framework
Beryl Keeley will be speaking at:
Panel Discussion and Q&A: Will regulation support or stifle the disruptive potential that e-cigarettes pose to the tobacco industry and smoking?
- 15:00 - 15:20
- 14:15 - 14:30
« Back to previous page